Revvity
Revvity provides health science solutions, technologies, expertise and services that deliver complete workflows from discovery to development, and diagnosis to cure. Revvity is revolutionizing what’s possible in healthcare, with specialized focus areas in translational multi-omics technologies, biomarker identification, imaging, prediction, screening, detection and diagnosis, informatics and more. Revvity serves customers across pharmaceutical and biotech, diagnostic labs, academia and governments.
Latest Content
Webinar
Will AI Transform the Way We Edit Genes?
In this webinar, our experts will showcase how AI-engineered base editors are achieving unprecedented precision and efficiency in therapeutic development.
Product News
Revvity Unveils New AI Software Offering To Transform Preclinical Imaging Analysis
Revvity’s new AI-powered imaging software unifies multimodal analysis to streamline workflows and speed discovery.
eBook
Reveal Cellular Secrets With Live-Cell Imaging
This eBook explores the advantages of live-cell imaging, the hurdles it presents and innovative solutions that support reliable, long-term assays.
eBook
Advancing Innovation With Monochromator Multimode Detection
This eBook explores the advantages of this technology, its applications across research areas and how integrated software solutions can enhance productivity from measurement to analysis.
Whitepaper
Reimagining Immunoassays With End-to-End Integrated Solutions
This whitepaper explores how comprehensive immunoassay ecosystems can address these limitations by integrating instruments, reagents, automation and software into cohesive solutions that streamline workflows from sample preparation to data analysis.
Product News
Revvity Establishes In Vivo Imaging Center of Excellence in North Carolina
Revvity has opened an In Vivo Imaging Center of Excellence in North Carolina to accelerate next-gen imaging innovation.
Industry Insight
Overcoming In Vivo Delivery Challenges With Image-Guided Innovation
Dr. Tomek Czernuszewicz shares insights on the limitations of traditional delivery techniques and how Revvity is advancing in vivo imaging through AI-powered tools.
Product News
Revvity’s EUROIMMUN Unveils New Fully Automated Instrument for Specialty Testing
Revvity launches the IDS i20™ platform, automating chemiluminescence immunoassays for multiple diagnostic specialties, increasing throughput and flexibility.
Listicle
RNA Therapeutics: Four Key Modalities Reshaping Medicine
This listicle explores four major RNA therapeutic modalities, highlighting their breakthroughs, challenges and future potential.
Industry Insight
Shaping the Future of Newborn Screening
Dr. Madhuri Hegde discusses Revvity's role in the Generation Study, an ambitious initiative that will sequence the genomes of 100,000 newborns.
Advertisement
